Zusammenfassung
Die Qualität antihypertensiver Substanzen, die häufig jahrelang verabreicht werden, ist neben ihrer antihypertensiven Potenz in besonders hohem Maße von der Anzahl und Intensität ihrer Nebenwirkungen abhängig.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Heimsoth V, Bock KD: Ergebnisse der Notfall- und Langzeitbehandlung mit 2-(2,6-Dichlorphenylamino)-2-imidazolin. In: Hoehdrucktherapie. Hrsg: L Heilmeyer, HJ Holtmeier und EF Pfeiffer. Stuttgart: Thieme 1968, S. 137.
Mroczek WJ, Davidoval M, Finnerty FA: Prolonged treatment with Clonidine: comparative antihypertensive effects alone and with a diuretic agent. Amer J Cardiol 30:536 (1972).
Conolly ME, Briant RH, George CF, Dollery CT: A crossover comparison of Clonidine and methyldopa in hypertension. Europ J clin Pharmacol 4:222–227 (1972).
Ng J, Phelan EL, McGregor DD, Laverty R, Taylor KM, Smirk Sir FH: Properties of cata-pres, a new hypotensive drug. A preliminary report. NZ med J 66:864 (1967).
Becker-Christensen F, Bang HO, Ditzel J: Treatment of severe hypertension with catapres. Acta med scand vol 190:21–26 (1971).
Conner CS, Watanabe AS: Clonidine overdose: A review. Amer J Hosp Pharm 36:906–911 (1979).
Lehmann A: Vergiftungsfâlle mit Clonidin. Schweiz Rundsch Med (Praxis) 70:1497–1500 (1981).
Rotellar JAO, Monasterio ES, De La Cruz JS, Gene CG: Clonidine in thousand-fold overdose. The Lancet, June 13 (1981).
Schwarz D, Michel D, Strian F: Depressive Reaktionen unter antihypertensiver Behandlung. Arch Psychiat Nervenkr 218:41–50 (1973).
Safar M, Sobel A, Milliez P: Antihypertensive effect of Clonidine and salt depletion in severe hypertension: Clinical and haemodynamic study. Europ J clin Pharmacol 5:203–209 (1973).
Chrysant SG, Dillard BL, Smith JW, Manion Cval: Antihypertensive effectiveness of Clonidine and chlorthalidone as step 1 drugs. Cur Ther Res 30:943 (1981).
Trial MRC: Medical research council working party on mild to moderate Hypertension: Adverse reactions to Bendrofluazide and Propranolol for the treatment of mild hypertension. Lancet 8246:539 (1981).
Davidoval M, Kakaviatos N, Finnerty FA, Jr: The antihypertensive effects of an imidazoline compound (Catapres). A preliminary clinical and hemodynamic evaluation in man. Clin Pharmacol Ther 8:810 (1967).
Koch M: Natrium- und Wasserhaushalt bei spontan-hypertensiven Ratten unter Clonidin. Clonidin-Workshop 1982 (ed: Bock KD, Hayduck K) im Druck.
Campese VM, Romoff M, Telfer N, Weidmann P, Massry SG: Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of Clonidine in essential hypertension. Kidney Int 18:351–357 (1980).
Yeh BK, Nantel A, Goldberg LI: Antihypertensive effect of Clonidine. Arch Intern Med 127:233–237(1971).
Thormann J, Neuss H, Horn H, Schlepper M: Clonidin-induzierte Bradykardie. Dtsch med Wschr 106:141–145 (1981).
Keränen A, Nykänen S, Taskinen J: Pharmacokinetics and side-effects of Clonidine. Europ J clin Pharmacol 13:97–101 (1978).
Anavekar SN, Jarrott B, Toscano M, Louis WJ: Pharmacokinetic and pharmacodynamic studies of oral Clonidine in normotensive subjects. Eur J Clin Pharmacol 23:1–5 (1982).
Frisk-Holmberg M: Effect concentration relationships of Clonidine in essential hypertension. Clonidin-Workshop 1982 (ed: Bock KD, Hayduck K) im Druck.
Kirch W, Distler A: Cross-over-Doppelblindstudie über die antihypertensive Wirkung von N-Amidino-2-(2,6-Dichlorphenyl)Acetamid-Hydrochlorid und Clonidin. Verh dtsch Ges inn Med 83:318 (1977).
Reid JL, Dargie HJ, Davies DS, Wing LMH, Hamilton CA, Dollery CT: Clonidine withdrawal in hypertension. Lancet 1:1171 (1977).
Hoobler SW, Kashima T: Central nervalous system actions of Clonidine in hypertension. Mayo Clin Proc 52:395 (1977).
Anderson RJ, Ram CvalS, Kaplan NM: Abrupt discontinuation of Clonidine therapy: Monitoring the blood pressure changes in outpatients with a semiautomatic blood pressure recording device. Clin Res 27:311A (1979).
Geyskes GG, Boer P, Dorhout Mees EJ: Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol 7:55 (1979).
Whitsett TL: Abrupt cessation of Clonidine administration: A prospective study. Am J Cardiol 41:1285(1978).
Planz G, Beckenbauer U, Bundschu HD: Response of plasma catecholamines and blood pressure to Clonidine and to sudden withdrawal of the drug in subjects with essential hypertension. Int J clin Pharmacol 20:474 (1982).
Weber MA: Discontinuation syndrome following cessation of treatment with Clonidine and other antihypertensive agents. J Cardiovasc Pharmacol 2: Suppl. 1, 73 (1980).
Burden AC, Alexander CPT: Rebound hypertension after acute methyldopa withdrawal. Br Med J 1:1056(1976).
Scott JN, McDevitt DG: Rebound hypertension after acute methyldopa withdrawal. Br Med J 2:367(1976).
Kristensen BO, Steiness E, Weeks J: Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clin Pharmacol Ther 23:624 (1978).
Miller RR, Olson HG, Amsterdam EA, Mason DT: Propranolol withdrawal rebound phenomenon. N Engl J Med 293:416 (1975).
Packer M, Meller J, Medina N, Gorlin R, Hermann Mval: Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure. N Engl J Med 301:1193 (1979).
Keim HJ, Drayer JIM, Case DB, Lopez-Ovejero J, Wallace JM, Weber MA, Laragh JH: A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate. N Engl J Med 295:1175 (1976).
Thoolen MJMC, Timmermann PBMWM, van Zwieten PA: The Clonidine withdrawal syndrome, its reproduction and evaluation in laboratory animal models. Gen Pharmac 12:303 (1981).
Rebound Hypertension. The Catapres Record. Ed by Boehringer Ingelheim, 1976.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this chapter
Cite this chapter
Philipp, T. (1983). Nebenwirkungen von Clonidin. In: Hayduk, K., Bock, K.D. (eds) Zentrale Blutdruckregulation durch α 2-Rezeptorenstimulation. Steinkopff. https://doi.org/10.1007/978-3-642-48440-7_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-48440-7_23
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-0624-4
Online ISBN: 978-3-642-48440-7
eBook Packages: Springer Book Archive